关键词：灰指甲治疗；真菌病治疗；市场规模；甲癣；局部治疗；全身治疗
摘 要：This report covers the present scenario and the growth prospects of the Global Dermatophytic Onychomycosis Therapeutics market for the period 2012-2016. It also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. To calculate the market size, the report considers revenue generated from the sales of various therapies such as topical treatment products and systemic therapy products used in the treatment of dermatophytic onychomycosis. In addition, the report discusses the major drivers that influence the growth of the Global Dermatophytic Onychomycosis Therapeutics market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
目 录： 01. Executive Summary

02. Scope of the Report

02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Types of Dermatophytic Onychomycosis

06.1.1 Distal Subungual Onychomycosis

06.1.2 Proximal Subungual Onychomycosis

06.1.3 White Superficial Onychomycosis

06.1.4 Candidal Onychomycosis

07. Currently Approved Drugs

07.1 Oral Agents

07.1.1 Terbinafine

07.1.2 Itraconazole

07.1.3 Griseofulvin

07.1.4 Fluconazole

07.2 Topical Agents

07.2.1 Ciclopirox

07.2.2 Amorolfine

07.2.3 Ketoconazole

08. Market Landscape

08.1 Market Overview

08.2 Market Size and Forecast

08.3 Dermatophytic Onychomycosis Therapeutics Market in the US

08.3.1 Market Segmentation

08.3.2 Itraconazole Sales in the US

08.3.3 Flucanozole Sales in the US

08.3.4 Griseofulvin Sales in the US

08.3.5 Ketoconazole Sales in the US

08.4 Five Forces Analysis

09. Geographical Segmentation

09.1 Global Dermatophytic Onychomycosis Therapeutics Market by Geographical Segmentation 2012-2016

10. Rate of Incidence and Prevalence

11. Pipeline Analysis

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Anacor Pharmaceuticals Inc

20.1.1 Business Overview

20.1.2 Key Information

20.1.3 SWOT Analysis

20.2 Janssen Biotech Inc

20.2.1 Business Overview

20.2.2 Key Information

20.2.3 SWOT Analysis

20.3 Novartis International AG

20.3.1 Business Overview

20.3.2 Business Segmentation

20.3.3 Key Information

20.3.4 SWOT Analysis

20.4 Pfizer Inc.

20.4.1 Business Overview

20.4.2 Business Segmentation

20.4.3 Key Information

20.4.4 SWOT Analysis

21. Other Reports in this Series